BIO Deutschland e.V. welcomes the European Commissions move towards a European Biotech Act to restore the competitiveness of the biotechnology industry, remove existing barriers for businesses and promote Europe as a location for innovation. As the Biotech Act itself rightly describes, biotechnology is one of the sectors that shapes the future.
BDV
BIO Deutschland e.V.
Industry association · Germany · EU Transparency Register 66742324074-50
4
positions filed
in the 326 files tracked
3
legislative files
of 326 tracked
4
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #448 by legislative files engaged — a count of participation, not a measure of influence.
1
declared lobbying FTE
self-declared
€1M+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2010
in the register since
Declares membership of
- Bundesverband der Deutschen Industrie e.V. (BDI e.V.)
- EUCOPE - European Confederation of Pharmaceutical Entrepreneurs AISBL
- EuropaBio →
- European Biosolutions Coalition →
- Bundesverband Deutscher Innovations-
- Technologie- und Gründerzentren e.V. (BVIZ)
- International Council for the Life Sciences (ICLS)
- GHA - German Health Alliance
- BioEconomy e. V.
- Industrieverbund Weiße Biotechnologie e. V. (IWBio)
- glyconet Berlin Brandenburg e. V.
- Biotechnology Innovation Organization (BIO).
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Trade and business associations
- Registered as
- BIO Deutschland
- Head office
- Berlin, Germany
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track BIO in PolicySpeak: request access →
Work at BIO Deutschland e.V.? so we know who speaks for it.
Their record over time
BIO Deutschland e.V. filed 4 positions between 6 Jun 2025 and 8 Jun 2026, across 3 of the 326 legislative files tracked here, attaching a full position paper 4 times.
2025 · 2 filed2026 · 2 filed
What they argued
BIO Deutschland welcomes an EU Biotech Act. In order to leverage the power of biotechnology, the EU Biotech Act must strengthen Europes global position in the development of this strategic technology through an ambitious, cross-sectoral approach.
Bio Germany, as the industry association of the German biotech industry and the Industrial Biotechnology Cluster (CLIB), welcomes the EU Biotech Act I as an important step for health biotechnology. For the planned EU Biotech Act II, we call for a focus on industrial biotechnology and biomanufacturing to ensure Europe’s innovative capacity and competitiveness in the bioeconomy.
Filed in German · English published by the European Commission
While the exemption is intended to prevent the automatic classification of young companies as undertakings in difficulty under Article 2(18) of the General Block Exemption Regulation (GBER), it does not address the full complexity of early-stage business realitiesparticularly in capital-intensive and research-driven sectors such as biotechnology, clean technology, and deep tech.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- AseBio · 3 files in common
- hollandbio · 3 files in common
- IDEE ECONOMICHE www.idee-economiche.it · 2 files in common
- Cefic · 2 files in common
- Danish Industry · 2 files in common
Showing 5 of 82.
Is this your organization?
Everything on this page comes from BIO Deutschland e.V.’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.